Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant ...
A UC San Francisco analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new ...
A new class of drug for type 2 diabetes could save thousands of lives each year, a study has found. Researchers described the once-daily SGLT-2 inhibitor tablets as working “very well” for a wide ...
A UCSF analysis has found that the newer generation of much more effective diabetes medications are reaching only a fraction of the patients who are recommended to take them based on new guidelines.
The new type 2 diabetes treatment algorithm consensus statement from the American Association of Clinical Endocrinologists (AACE), running to 48 pages, has been published online and is available for ...
Electronic health records used to bridge gap on benefits of SGLT-2 inhibitors for type 2 diabetesDiabetes drugs that may soon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results